✦ LIBER ✦

The War to Be Ended as a "Draw": As Viewed from Chinese Interests

✍ Scribed by Gilbert Reid

Book ID: 123863848
Publisher: JSTOR
Year: 1916
Weight: 710 KB
Volume: 7
Category: Article
ISSN: 1068-3380
DOI: 10.2307/29738181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

"A REPLY TO CHILDRESS": THE SELECTION PR

"A REPLY TO CHILDRESS": THE SELECTION PROCESS AS VIEWED FROM WITHIN

✍ FREDERIC B. WESTERVELT, JR. 📂 Article 📅 1970 🏛 The Pennsylvania State University Press 🌐 English ⚖ 570 KB

Should active recruitment of health work

Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime?

✍ Edward J Mills; William A Schabas; Jimmy Volmink; Roderick Walker; Nathan Ford; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 96 KB

(1) A Course of Drawing for the Standard

(1) A Course of Drawing for the Standards Being a Selection of Sheets from “A Complete Course of Free-Arm and Industrial Drawing” (2) Natural and Common Objects in Primary Drawing, with Full Directions as to Their Use A Handbook for Teachers

📂 Article 📅 1910 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

Kant’s view on the parent-child relation

Kant’s view on the parent-child relationship and its problems—Analyses from a temporal perspective as to the creation and rearing of a being endowed with freedom

✍ Xianglong Zhang 📂 Article 📅 2011 🏛 Higher Education Press and Springer 🌐 English ⚖ 458 KB

Noninvasive Ventilation for the Treatmen

Noninvasive Ventilation for the Treatment of Dyspnea as a Bridge from Intensive to End-of-Life Care

✍ Sebastiano Mercadante; Patrizia Villari; Fabrizio David; Cristina Agozzino 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Can prostate-specific antigen be used as

Can prostate-specific antigen be used as a valid end point to determine the efficacy of chemotherapy for advanced prostate cancer?

✍ B. Seckin; C. T. Anthony; B. Murphy; M. S. Steiner 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 444 KB

It is current practice in many clinical trials evaluating new chemotherapy regimens for the treatment of advanced prostate cancer to use prostate-specific antigen (PSA) decline as a response criteria with the assumption that the level of PSA reflects the efficacy of chemotherapy. Advanced prostate c